Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis

NCT00523341 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4550

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteopenia
Osteoporosis

Interventions

BIOLOGICAL: Denosumab

Sponsor

Amgen